Guidant Can't Kill $726M FCA Suit Over Implant Claims

Law360, New York (March 15, 2012, 1:56 PM EDT) -- A whistleblower on Wednesday defeated a bid by Boston Scientific Corp. and its Guidant LLC unit to dismiss his complaint in Minnesota claiming Guidant — which copped to related criminal charges — caused the U.S. to pay $726 million in false claims for defective cardiac implants.

U.S. District Judge Donovan W. Frank denied the defendants' motion to dismiss a False Claims Act claim brought by relator James Allen, who was implanted with one of the allegedly defective devices, but he granted the bid as to Allen's...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.